At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 20 enrolled
Drug / intervention
Fentanyl Citrate 50Mcg/Ml Inj_#1 +1 moredrug
Likely dose
Fentanyl Citrate 50Mcg/Ml Inj_#1from record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy of Injectable Fentanyl in Sublingual Route Versus Oral Morphine Syrup for Breakthrough Pain in Gynecologic Cancer Patients With Chronic Cancer Pain : A Randomized Double Blind Controlled Trial
Department of Medical Services Ministry of Public Health of Thailand·interventional·Posted Sep 8, 2021·Updated Aug 31, 2022
In Brief
A Phase 2 clinical trial evaluating Fentanyl Citrate 50Mcg/Ml Inj_#1 and Morphine for Pain, Breakthrough. Completed, enrolled 20 participants across 1 site.
Detailed Summary
Randomized control trial that to comparison the efficacy of injectable fentanyl in sublingual route versus oral morphine syrup for breakthrough pain in gynecologic cancer patients with chronic cancer pain Primary outcome : to measure pain score after drug is given
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Breakthrough
CountriesThailand
Collaborators--
Timeline
Phase 2CompletedFinished
20222023202420252026
Enrollment StartJun 2021
First PostedSep 2021
Primary CompletionDec 2021
Study CompletionJun 2022
TodayJul 2026
First PostedSep 8, 2021
Enrollment StartJun 15, 2021
Primary CompletionDec 30, 2021
Study CompletionJun 30, 2022
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 4.8 years ago
Interventions
Fentanyl Citrate 50Mcg/Ml Inj_#1drug
Injectable Fentanyl in Sublingual Route 50 mcg
Morphinedrug
Oral Morphine Syrup 2.5 ml ( 5 mg)